Referencias bibliográficas

1. Shilo M; Reuveni T; Motiei M; Popovtzer R.Nanoparticles as Computed Tomography Contrast Agents Current Status and Future Perspectives. Nanomedicine. 2012;7(2):257-9
2. Berrington de González A, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009; 169(22):2071–7
3. IOM Washington, DC:Institute of Medicine, The National Academies (7 Dec 2011). Breast Cancer and the Environment: A Life Course Approach. Disponible en:
http://www.iom.edu/Reports/2011/Breast-Cancer-and-the-Environment-A-Life-Course-Approach.aspx Último acceso junio 2012
4. AAPMCollege Park, MD:The American Association of Physicists in Medicine (13 Dec 2011). Professional/Education/Science Policies. Disponible en:
http://www.aapm.org/org/policies/details.asp?id=318&type=PP¤t=true. Último acceso junio 2012
5. State of California Legislature Bill SB 1237: Radiation Control: Health Facilities and Clinics: Records. Effective 29 Sep 2010. Disponible en:
http://www.leginfo.ca.gov/pub/09-10/bill/sen/sb_1201-1250/sb_1237_bill_20100929_chaptered.html. Último acceso junio 2012..
6. FDA Washington, DC:U.S. Food and Drug Administration (9 Feb 2010). FDA unveils initiative to reduce unnecessary radiation exposure from medical imaging [press release].Disponible en:
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm200085.htm Último accesos junio 2012
7. Beebe Symposium: Tracking Radiation Exposure from Medical Diagnostic Procedures, Washington, DC, 8–9 Dec 2011. Washington, DC:Nuclear & Radiation Studies Board, National Academy of Sciences (2011). Disponible en:
www.tvworldwide.com/events/nas/111208/ Último acceso junio 2012
8. Vries A, Custers E, Lub J, Van Den Bosch S, Nicolay K, Grull H. Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents. Biomaterials312010;(25),6537–44
9. Budoff MJ, Cohen MC, Garcia MJ, Hodgson JM, Hundley WG, Lima JA, et al. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. Circulation. Jul 26 2005; 112(4):598-617..
10. Weinreb JC, Larson PA, Woodard PK, Stanford W, Rubin GD, Stillman AE, et al. American College of Radiology clinical statement on noninvasive cardiac imaging. Radiology. Jun 2005;235(3):723-7.
11. Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T. Iodinated blood pool contrast media for preclinical x-ray imaging applications – a review. Biomaterials 2010; (24),6249–68
12. Kweon S, Lee H-J, Hyung WJ, Suh J, Lim JS, Lim S-J. Liposomes coloaded with iopamidol/lipiodol as a RES-targeted contrast agent for computed tomography imaging. Pharm. Res 2010;7(7),1408–15
13. Budoff MJ, Cohen MC, Garcia MJ, Hodgson JM, Hundley WG, Lima JA, et al. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol. Jul 19 2005;46(2):383-402.
14. Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. Dec 2009;169:2078-86.
15. Huang B, Li J, Zhang J, et al. Radiation dose and cancer risk in retrospectively and prospectively ECG-gated coronary angiography using 64-slice multidetector CT. Br J Radiol. Feb 2010;83:152-8.
16. Patel MR, Peterson ED, Dai D et al. Low diagnostic yield of elective coronary angiography. NEJM. March 2010;362:886-95.
17. Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano 2010; 4(11),6303–17
18. Skotland T, Iversen T-G, Sandvig K. New metal-based nanoparticles for intravenous use: requirements for clinical success with focus on medical imaging. Nanomedicine 2010; 6(6),730–7
19. Shilo M; Reuveni T; Motiei M; Popovtzer R.Nanoparticles as Computed Tomography Contrast Agents Current Status and Future Perspectives. Nanomedicine. 2012;7(2):257-9
20. Ghaghada KB, Badea CT, Karumbaiah L et al. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad. Radiol.18(1),20–30 (2011).
21. Aviv H, Bartling S, Kieslling F, Margel S. Radiopaque iodinated copolymeric nanoparticles for x-ray imaging applications. Biomaterials30 2009;(29),5610–6
22. Galperin A, Margel D, Baniel J, Dank G, Biton H, Margel S. Radiopaque iodinated polymeric nanoparticles for x-ray imaging applications. Biomaterials 2007; 28(30),4461–8
23. De Vries A, Custers E, Lub J, Van Den Bosch S, Nicolay K, Grull H. Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents. Biomaterials 2010; 31(25),6537–44.